The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MAGNIFY: A randomized, phase 3b trial in patients with relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL) investigating lenalidomide plus rituximab (R2) induction followed by maintenance R2 followed by lenalidomide versus R2 induction followed by rituximab (R) maintenance.
 
David Jacob Andorsky
Research Funding - Celgene; CTI; Gilead Sciences; Janssen
 
Paula J. Franson
Employment - Celgene
Stock and Other Ownership Interests - Celgene; Pharmacyclics
Travel, Accommodations, Expenses - Celgene
 
Jorge L Mouro
Employment - Celgene
Stock and Other Ownership Interests - Celgene
Travel, Accommodations, Expenses - Celgene
 
Jiahui Li
Employment - Celgene; Janssen Research & Development
Stock and Other Ownership Interests - Celgene; Janssen Research & Development
 
Kenneth A. Foon
Employment - Celgene
Stock and Other Ownership Interests - Celgene
Travel, Accommodations, Expenses - Celgene
 
Jeff Porter Sharman
Honoraria - Celgene
Consulting or Advisory Role - Celgene
Research Funding - Celgene
Travel, Accommodations, Expenses - Celgene